Abstract
Benzodiazepines are the oldest class of antispasticity drugs and continue to have widespread clinical use (1). Although several more recently developed medications are now used more frequently than benzodiazepines, this class of drug still has a place in the management of spasticity, especially as adjunctive therapy and for the treatment of nocturnal spasms. The following will review the mechanisms of action and pharmacology, clinical trials, and administration of benzodiazepines, specifically as it relates to spasticity management.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Whyte, J. and Robinson, K. M. (1990) Pharmacologic management, in The Practical Management of Spasticity in Children and Adults ( Glen, M. B. and Whyte, J., eds.), Lea and Febiger, Philadelphia, pp. 210–226.
Ballenger, J. C. (1995) Benzodiazepines, in The American Psychiatric Press Textbook of Psychopharmacology ( Schatzberg, A. F. and Nemeroff, C. B., eds.), American Psychiatric Press, Washington DC, p. 215.
Randall, L. O. (1982) Discovery of benzodiazepines, in Pharmacology of Benzodiazepines ( Usdin, E., Skolnick, R, and Tallman, J. F., eds.), MacMillan Press, London, pp. 15–22.
Randall, L. O., Heise, G. A., and Schallek, W., et.al. (1961) Pharmacological and clinical studies on valium, a new psychotherapeutic agent of the benzodiazepine class. Curr. Ther. Res. 3, 405–421.
Kendall, H. P. (1964) The use of diazepam in hemiplegia. Ann. Phys. Med. 7 (6), 225–228.
Simpson, C. A. (1964) Use of diazepam for the relief of spasticity in multiple sclerosis. Ann. Phys. Med. (Suppl.), 39–40.
Neill, R. W. K. (1964) Diazepam in the relief of muscle spasm resulting from spinal cord lesions. Ann. Phys. Med. (Suppl.), 33–38.
Hardman, J. G. (1996) Drugs acting on the central nervous system, in The Pharmacologic Basis of Therapeutics, 9th ed. ( Goodman, L. S. and Gilman, A. G., eds. ), McGraw Hill, pp. 361–373.
Ngai, S. H., Tseng, D. T. C., and Wong, S. C. (1966) Effect of diazepam and other central nervous system depressants on spinal reflexes in cats: a study of site of action. J. Pharm. Exp. Ther. 153, 344–351.
Cook, J. B. and Nathan, R. W. (1967) On the site of action of diazepam in spasticity in man. J. Neurol. Sci. 5, 33–37.
Verrier, M., Ashby, P., and MacLeod, S. (1976) Effect of diazepam on muscle contraction in spasticity. Am. J. Phys. Med. 55, 184–191.
Verrier, M., Ashby, P., and MacLeod, S. (1977) Diazepam effect on reflex activity in patients with complete spinal lesions and in those with other causes of spasticity. Arch. Phys. Med. Rehabil. 58, 148–153.
Schmidt, R. F., Vogel, M. E., and Zimmermann, M. (1967) Die Wirkung von diazepam auf die prasynaptische hemmung und andere ruckenmarksreflexe. Naunyn Schmiedebergs Arch. Pharmacol 258, 69–82.
Haefely, W., Kulcsar, A., and Mohler, H., et al. (1975) Possible involvement of GABA in the central actions of benzodiazepines. Adv. Biochem. Psychopharmacol. 14, 131–152.
Polc, P., Mohler, H., and Haefely, W. (1974) The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. Naunyn. Schmiedebergs. Arch. Pharmacol. 284, 319–339.
Curtis, D. R., Lodge, D., and Johnston, G. A. R., et al. (1976) Central actions of benzodiazepines. Brain Res. 118, 344–347.
Macdonald, R. L. and Barker, J. L. (1978) Benzodiazepines specifically modulate GABA mediated postsynaptic inhibition in cultured mammalian neurones. Nature 267, 720–721.
Costa, E. and Guidotti, A. (1979) Molecular mechanisms in the receptor action of benzodiazepines. Ann. Rev. Pharmacol. Toxicol. 19, 531–545.
Skerritt, J. H. and Johnston, G. A. R. (1983) Enhancement of GABA binding by benzodiazepines and related anxiolytics. Eur. J. Pharmacol. 89, 193–198.
Skerritt, J. H., Willow, M., and Johnston, G. A. R. (1982) Diazepam enhancement of low affinity GABA binding to rat brain membranes. Neurosci. Lett. 29, 63–66.
Study, R. E. and Barker, J. L. (1982) Diazepam and pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gammaaminobutyric acid responses in cultured central neurons. Proc. Natl. Acad. Sci. USA 78, 7180–7184.
Davidoff, R. A. (1985) Antispasticity drugs: mechanisms of action. Ann. Neurol. 17 (2), 107–116.
Gracies, J. M., Nance, P., Elovic, E., McGuire, J., and Simpson, D. M. (1997) Traditional pharmacologic treatments for spasticity Part II: general and regional treatments. Muscle Nerve 20(Suppl. 6), S92-S 120.
Lossius, R., Dietrichson, P., and Lunde, P. K. M. (1985) Effect of clorazepate in spasticity and rigidity: a quantitative study of reflexes and plasma concentrations. Acta. Neurol. Scand. 71, 190–194.
Corbett, M., Frankel, H. L., and Michaelis, L. (1972) A double blind cross-over trial of valium in the treatment of spasticity. Paraplegia 10, 19–22.
Cartlidge, N. E. F., Hudgson, P., and Weightman, D. (1974) A comparison of baclofen and diazepam in the treatment of spasticity. J. Neurol. Sci. 23, 17–24.
From, A. and Heltberg, A. (1975) A double-blind trial of baclofen and diazepam in spasticity due to multiple sclerosis. Acta. Neurol. Scand. 51, 158–166.
Roussan, M., Terrence, C., and Fromm, G. (1987) Baclofen versus diazepam for the treatment of spasticity and long-term follow-up of baclofen therapy. Pharmatherapeutica 4, 278–284.
Schmidt, R. T., Lee, R. H., and Spehlman, R. (1976) Comparison of dantrolene sodium and diazepam treatment of spasticity. J. Neurol. Neurosurg. Psychiatry 39, 350–356.
Cocchiarella, A., Downey, J. A., and Darling, R. C. (1967) Evaluation of the effect of diazepam on spasticity. Arch. Phys. Med. Rehabil. 49, 393–396.
Engle, H. A. (1966) The effect of diazepam (Valium) in children with cerebral palsy: a double blind study. Dev. Med. Child. Neurol. 8, 661–667.
Dahlin, M., Knutsson, E., and Nergardh, A. (1993) Treatment of spasticity in children with low dose benzodiazepine. J. Neurol. Sci. 117, 54–60.
Glenn, M. B. (1986) Antispasticity medications in the patient with traumatic brain injury. J. Head. Trauma Rehabil. 1, 71–72.
Wilson, L. A. and McKechnie, A. A. (1966) Oral diazepam in the treatment of spasticity in paraplegia. A double blind trial and subsequent impressions. Scott Med. J. 11, 46–51.
Delwaide, P. J., Martinelli, P., and Crenna, P. Clinical neurophysiological measurement of spinal reflex activity, in Spasticity: Disordered Motor Control (Feldman, R. G., Young, R.R., and Koella, W. P., eds.), YearBook, Chicago, pp. 345–371.
Glass, A. and Hannah, A. (1974) A comparison of dantrolene sodium and diazepam in the treatment of spasticity. Paraplegia 12, 170–174.
Rudick, R. A., Goodkin, D. E., and Ransohoff, R. M. (1992) Pharmacology of multiple sclerosis: current status. Cleveland Clin. J. Med. 59, 267–277.
Gelber, D. A. and Jozefczyk, P. B. (1999) Therapeutics in the management of spasticity. Neurorehabil. Neural Repair 13, 5–14.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Karpatkin, H.I., Aisen, M.L. (2002). Benzodiazepines. In: Gelber, D.A., Jeffery, D.R. (eds) Clinical Evaluation and Management of Spasticity. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-092-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-59259-092-6_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-109-7
Online ISBN: 978-1-59259-092-6
eBook Packages: Springer Book Archive